Cohort protocol paper: The pain and opioids in treatment (POINT) study

BMC Pharmacology and Toxicology

Volumn 15, Issue 1, 2014, Pages

  Campbell, Gabrielle ^a   Mattick, Richard ^a   Bruno, Raimondo ^a,b   Larance, Briony ^a   Nielsen, Suzanne ^a,c,d   Cohen, Milton ^e   Lintzeris, Nicholas ^c,d   Shand, Fiona ^f   Hall, Wayne D ^g,h   Hoban, Bianca ^a   Kehler, Chyanne ^a   Farrell, Michael ^a   Degenhardt, Louisa ^a,i,j,k  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e ST VINCENT'S CLINIC   (Australia)

^f BLACK DOG INSTITUTE   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h KING'S COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^k UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Chronic non cancer pain; Dependence; Non adherence; Opioids; Pain; Quality of life

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ABERRANT MEDICATION BEHAVIOR; ADVERSE DRUG REACTION; ALCOHOL CONSUMPTION; ANALGESIA; ARTICLE; AUSTRALIA; CHRONIC NON CANCER PAIN; CHRONIC PAIN; CLINICAL PROTOCOL; COHORT ANALYSIS; DATA ANALYSIS; DATA LINKAGE; DATA PROCESSING; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG OVERDOSE; DRUG USE; HEALTH BEHAVIOR; HEALTH CARE CONCEPTS; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; MEDICARE; MEDICATION DIVERSION; MENTAL HEALTH; MORTALITY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; QUALITY OF LIFE; SELF REPORT; STUDY DESIGN; TIME SERIES ANALYSIS; ADOLESCENT; CLINICAL PRACTICE; DRUG UTILIZATION; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ANALGESICS, OPIOID; AUSTRALIA; CHRONIC PAIN; COHORT STUDIES; DRUG OVERDOSE; DRUG UTILIZATION; HUMANS; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 84908126600     PISSN: None     EISSN: 20506511     Source Type: Journal    
DOI: 10.1186/2050-6511-15-17     Document Type: Article

References (71)

1. Blyth FM, March LM, Brnabic AJM, Jorm LR, Williamson M, Cousins MJ: Chronic pain in Australia: a prevalence study. Pain 2001, 89(2-3):127-134.
2. Beubler E, Jaksch W, Devulder J, Le Poloin B, Bo Honsen O, Meynadier J, Muller-Schwefe G, Zenz M, Mac Sullivan R, O'Brien T, Beubler E, Jaksch W, Devulder J, Le Poloin B, Bo Honsen O, Meynadier J, Muller-Schwefe G, Zenz M, Mac Sullivan R, O'Brien T, Eisenberg E, Mercodante S, Ventafriddo V, Varrossi G, Vielvoye-Kerkmeer A, Zylicz B, Breivik H, Krajnik M, Lopez JC, Puig M, et al: The white paper on opioids and pain: A pan-European challenge: The European white paper on the use of opioids in chronic pain management. J Pain Palliat Care Pharmacother 2006, 20(3):79-87.
3. Savage SR: Opioid therapy of chronic pain: assessment of consequences. Acta Anaesthesiol Scand 1999, 43(9):909-917.
4. Blyth FM, March LM, Brnabic AJM, Cousins MJ: Chronic pain and frequent use of health care. Pain 2004, 111(1-2):51-58.
5. Blyth FM, March LM, Cousins MJ: Chronic pain-related disability and use of analgesia and health services in a Sydney community. Med J Aust 2003, 179(2):84-87.
6. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM: Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010, 1, CD006605.
7. Chou R: 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice? Polskie Archiwum Medycyny Wewnetrznej 2009, 119(7-8):469-477.
8. Kalso E, Edwards JE, Moore RA, McQuay HJ: Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004, 112(3):372-380.
9. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E: Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J 2006, 174(11):1589-1594.
10. Bloodworth D: Issues in opioid management. Am J Phys Med Rehabil 2005, 84(3 Suppl):S42-S55.
11. Eisenberg E, McNicol ED, Carr DB: Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur J Pain 2006, 10(8):667-667.
12. Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, Sehgal N, Shah R: A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician 2011, 14:91-121.
13. Ballantyne JC, Shin NS: Efficacy of Opioids for chronic pain: a review of the evidence. Clin J Pain 2008, 24(6):469-478.
14. Moulin DE, Amireh R, Sharpe WKJ, Boyd D, Merskey H, Iezzi A: Randomised trial of oral morphine for chronic non-cancer pain. The Lancet 1996, 347(8995):143-147.
15. American Academy of Pain Medicine and American Pain Society: The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society.
16. Cohen ML, Wodak AD: The judicious use of opioids in managing chronic noncancer pain. Medicine Today 2010, 11:10-18.
17. Royal Australasian College of Physicians: Prescription Opioid Policy: Improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use. Sydney: Royal Australasian College of Physicians; 2009.
18. Ballantyne JC: Opioids for chronic pain: taking stock. Pain 2006, 125:3-4.
19. Baca C, Grant K: Mortality from opioid analgesics must not be ignored. [comment]. Pain 2007, 128(3):288. author reply 288-289.
20. Ballantyne JC: Regulation of opioid prescribing. Br Med J 2007, 334(7598):811-812.
21. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK: Critical issues on opioids in chronic non-cancer pain: an epidemiological study. [see comment]. Pain 2006, 125(1-2):172-179.
22. Lipman AG: Treatment options for chronic pain management: opioids revisited. Manag Care 2007, 16(2 Suppl 3):5-9.
23. Leong M, Murnion B, Haber PS: Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009, 39(10):676-681.
24. Compton WM, Volkow ND: Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006, 81(2):103-107.
25. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN: Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Can Med Assoc J 2009, 181(12):891-896.
26. Centers for Disease -Control Prevention: Adult use of prescription opioid pain medications - Utah, 2008. MMWR - Morbidity & Mortality Weekly Report 2008, 59(6):153-157.
27. Compton WM, Thomas YF, Conway KP, Colliver JD, Compton WM, Thomas YF, Conway KP, Colliver JD: Developments in the epidemiology of drug use and drug use disorders. Am J Psychiatry 2005, 162(8):1494-1502.
28. Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC: Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010, 14(3):289-294.
29. Degenhardt L, Black E, Breen C, Bruno R: Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev 2006, 25(5):403-412.
30. Compton WM, Volkow ND: Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 2006, 83:S4-S7.
31. Paulozzi LJ, Budnitz DS, Xi Y: Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006, 15(9):618-627.
32. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS: What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Medicine 2008, 9(4):444-459.
33. Lintzeris N: Commentary on Minozzi et al. (2013): Diagnosing opioid dependence in the context of long-term opioid use for chronic pain- counting shades of grey in a black and white world. Addiction 2013, 108(4):699-700.
34. Reid MC, Henderson CR Jr, Papaleontiou M, Amanfo L, Olkhovskaya Y, Moore AA, Parikh SS, Turner BJ: Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes. Pain Medicine 2010, 11(7):1063-1071.
35. Hariharan J, Lamb GC, Neuner JM, Hariharan J, Lamb GC, Neuner JM: Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med 2007, 22(4):485-490.
36. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M: Opioid prescriptions for chronic pain and overdose: a cohort study.[Summary for patients in Ann Intern Med. 2010 Jan 19;152(2):I-42; PMID: 20083811]. Ann Intern Med 2010, 152(2):85-92.
37. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM, Disability Risk Identification Study C, Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM: Early opioid prescription and subsequent disability among workers with back injuries: the disability risk identification study cohort. Spine 2008, 33(2):199-204.
38. Pletcher MJ, Kertesz SG, Sidney S, Kiefe CI, Hulley SB, Pletcher MJ, Kertesz SG, Sidney S, Kiefe CI, Hulley SB: Incidence and antecedents of nonmedical prescription opioid use in four US communities. The Coronary Artery Risk Development in Young Adults (CARDIA) prospective cohort study. Drug Alcohol Depend 2006, 85(2):171-176.
39. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG: Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002, 17(3):173-179.
40. Hartung DM, Middleton L, Haxby DG, Koder M, Ketchum KL, Chou R: Rates of adverse events of long-acting opioids in a state Medicaid program. [Erratum appears in Ann Pharmacother. 2007 Sep;41(9):1552]. Ann Pharmacother 2007, 41(6):921-928.
41. Euser AM, Zoccali C, Jager KJ, Dekker FW, Euser AM, Zoccali C, Jager KJ, Dekker FW: Cohort studies: prospective versus retrospective. Nephron 2009, 113(3):c214-c217.
42. Kreidler SM, Muller KM, Grunwald G, Ringham BM, Coker-Dukowitz Z, Sakhadeo UR, Barón AE, Glueck DH: GLIMMPSE: Online Power Computation for Linear Models with and without a Baseline Covariate. Journal of Statistical Software 2013, 54(i10).
43. National Drug and Alcohol Research Centre: A Review of Opioid Prescribing in Tasmania: A Blueprint for the Future. Sydney: NDARC, University of New South Wales; 2012.
44. Therapeutic Goods Administration: Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). http://www.tga.gov.au/industry/schedulingpoisons- standard.htm. Accessed on 05/09/2013. Edited by Australian Government Department of Health and Ageing; 2013.
45. Maven Marketing: List of Pharmacies and Chemists in Australia. 2014 [accessed 2014 14th March]. In Available from: http://www.mavenmarketing. com.au/list-of-pharmacies-in-australia/.
46. Booker CL, Harding S, Benzeval M: A systematic review of the effect of retention methods in population-based cohort studies. BMC Public Health 2011, 11:249.
47. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, et al: Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005, 113(1-2):9-19.
48. Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, et al: Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003, 106(3):337-345.
49. Cleeland CS, Ryan KM: Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 1994, 23(2):129-138.
50. World Health Organization: Composite International Diagnostic Interview, Version 3.0. Geneva: World Health Organization; 2001.
51. Tan G, Jensen MP, Thornby JI, Shanti BF: Validation of the brief pain inventory for chronic nonmalignant pain. The Journal of Pain 2004, 5(2):133-137.
52. Centre for Disease Control and Prevention: Overview of Implementation Protocols for Testing the Washington Group Short Set of Questions on Disability. Washington DC: Centre for Disease Control and Prevention; 2006.
53. Bjorner J, Turner-Bowker D: SF-36 and SF-12 Health Surveys. In Encyclopedia of Medical Decision Making. Edited by Kattan M. Thousand Oaks, CA: SAGE Publications, Inc; 2009. doi:http://dx.doi.org/10.4135/ 9781412971980.
54. Rejas J, Ribera MV, Ruiz M, Masrramón X: Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain. Eur J Pain 2007, 11(3):329-340.
55. Nicholas MK: Self-efficacy and chronic pain. Annual conference of the British Psychological Society. St. Andrews: British Psychological Society; 1989.
56. Nicholas MK: The pain self-efficacy questionnaire: taking pain into account. Eur J Pain 2007, 11(2):153-163.
57. Hurst H, Bolton J: Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther 2004, 27(1):26-35.
58. Horne R, Weinman J, Hankins M: The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14(1):1-24.
59. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, Dodd SL, Schein JR: A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004, 26(4):552-561.
60. Mattick RP, Larance B, Bruno R, Black E, Lintzeris N, Degenhardt L, Mattick RP, Larance B, Bruno R, Black E, Lintzeris N, Degenhardt L, Nielsen S, Murnion B, Cohen M, Ali R, Dunlop A, Holland R: Minimising the unintended consequences of opioid treatment: development of a drug behaviour scale for use in Australia. Poster presentation at the College on Problems of Drug Dependence 74th Annual Meeting. CA: Palm Springs; 2012.
61. Banta-Green CJ, Von Korff M, Sullivan MD, Merrill JO, Doyle SR, Saunders K: The prescribed opioids difficulties scale: a patient-centered assessment of problems and concerns. Clin J Pain 2010, 26(6):489-497.
62. Murphy B, Herrman H, Hawthorne G, Pinzone T, Evert H: In Australian WHOQoL instruments: User's manual and interpretation guide. Edited by Centre AWFS. Melbourne, Australia: Australian WHOQoL Field Study Centre; 2000.
63. Kroenke K, Spitzer R, Williams JBW: The PHQ-9: Validity of a Brief Depression Severity Measure. J Gen Intern Med 2001, 16(9):606-613.
64. Martin A, Rief W, Klaiberg A, Braehler E: Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 2006, 28(1):71-77.
65. Spitzer RL, Kroenke K, Williams JBW, Lowe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166(10):1092-1097.
66. Mattick RP, Clarke JC: Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther 1998, 36(4):455-470.
67. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(20):22-33. quiz 34-57.
68. Prins A, Ouimette P, Kimerling R, Camerond RP, Hugelshofer DS, Shaw- Hegwer J, Thrailkill A, Gusman FD, Sheikh JI: The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary Care Psychiatry 2004, 9(1):9-14.
69. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W: Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child abuse & neglect 2003, 27(2):169-190.
70. Sherbourne CD, Stewart A: In The MOS Social Support Survey. Edited by Corporation R. Santa Monica, CA: RAND Corporation; 1993.
71. Wallston KA, Wallston BS, DeVellis R: Development of the multidimensional health locus of control (MHLC) scales. Health Education Monographs 1978, 6:160-170.